Alison Wolfreys

1.0k total citations
14 papers, 592 citations indexed

About

Alison Wolfreys is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Alison Wolfreys has authored 14 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Alison Wolfreys's work include Carcinogens and Genotoxicity Assessment (5 papers), Biosimilars and Bioanalytical Methods (3 papers) and Cholesterol and Lipid Metabolism (2 papers). Alison Wolfreys is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Biosimilars and Bioanalytical Methods (3 papers) and Cholesterol and Lipid Metabolism (2 papers). Alison Wolfreys collaborates with scholars based in United Kingdom, United States and Switzerland. Alison Wolfreys's co-authors include L.M. Henderson, Paul Hepburn, Paul Baldrick, Linda J. Lea, A.G. Renwick, Anne Constable, Gary M. Williams, Wout Slob, J. Schlatter and John O’Brien and has published in prestigious journals such as Journal of Bone and Mineral Research, Annals of the Rheumatic Diseases and Food and Chemical Toxicology.

In The Last Decade

Alison Wolfreys

14 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Wolfreys United Kingdom	10	229	204	141	111	90	14	592
Maha H. Elamin Saudi Arabia	11	157 0.7×	225 1.1×	245 1.7×	64 0.6×	74 0.8×	22	820
V.A Baker United Kingdom	11	116 0.5×	258 1.3×	225 1.6×	96 0.9×	68 0.8×	13	812
A.A.J.J.L. Rutten Netherlands	15	145 0.6×	262 1.3×	162 1.1×	81 0.7×	52 0.6×	34	843
Marcel H. M. van Herwijnen Netherlands	20	363 1.6×	490 2.4×	311 2.2×	91 0.8×	30 0.3×	34	1.0k
Freddy Van Goethem Belgium	17	296 1.3×	276 1.4×	203 1.4×	127 1.1×	27 0.3×	31	939
Moon‐Koo Chung South Korea	15	117 0.5×	161 0.8×	193 1.4×	84 0.8×	26 0.3×	49	709
Ryeo‐Eun Go South Korea	17	103 0.4×	305 1.5×	133 0.9×	59 0.5×	31 0.3×	46	777
Gladys Ouédraogo France	14	215 0.9×	150 0.7×	261 1.9×	107 1.0×	45 0.5×	25	781
Stuart Creton United Kingdom	14	144 0.6×	160 0.8×	214 1.5×	84 0.8×	19 0.2×	22	661
Michelle E. Bishop United States	16	336 1.5×	236 1.2×	122 0.9×	168 1.5×	15 0.2×	29	693

Countries citing papers authored by Alison Wolfreys

Since Specialization

Citations

This map shows the geographic impact of Alison Wolfreys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Wolfreys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Wolfreys more than expected).

Fields of papers citing papers by Alison Wolfreys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Wolfreys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Wolfreys. The network helps show where Alison Wolfreys may publish in the future.

Co-authorship network of co-authors of Alison Wolfreys

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Wolfreys. A scholar is included among the top collaborators of Alison Wolfreys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Wolfreys. Alison Wolfreys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wolfreys, Alison, Sherri Dudal, David Jones, et al.. (2021). Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals—The Outcome of a Cross-Industry Working Group Survey. Toxicologic Pathology. 49(2). 261–285. 3 indexed citations

Zabka, Tanja S., John E. Burkhardt, William J. Reagan, et al.. (2020). The use of emerging safety biomarkers in nonclinical and clinical safety assessment – The current and future state: An IQ DruSafe industry survey. Regulatory Toxicology and Pharmacology. 120. 104857–104857. 2 indexed citations

Holdsworth, Gill, James R Staley, Ian D. van Koeverden, et al.. (2020). Sclerostin Downregulation Globally by Naturally Occurring Genetic Variants, or Locally in Atherosclerotic Plaques, Does Not Associate With Cardiovascular Events in Humans. Journal of Bone and Mineral Research. 36(7). 1326–1339. 17 indexed citations

Prior, Helen, et al.. (2020). Justification for species selection for pharmaceutical toxicity studies. Toxicology Research. 9(6). 758–770. 43 indexed citations

Shock, Anthony, B. Kilgallen, C. Stach, et al.. (2015). FRI0002 Pharmacodynamic Effects of the CD22-Targeted Monoclonal Antibody Epratuzumab on B Cells in Cynomolgus Monkeys and in Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 74. 420–420. 2 indexed citations

Brennan, Frank R., Annick Cauvin, Jay Tibbitts, & Alison Wolfreys. (2014). Optimized Nonclinical Safety Assessment Strategies Supporting Clinical Development of Therapeutic Monoclonal Antibodies Targeting Inflammatory Diseases. Drug Development Research. 75(3). 115–161. 13 indexed citations

Wu, Jian, James B. Wilson, Alison Wolfreys, Andrew D. Scott, & Nigel J. Jones. (2008). Optimization of the comet assay for the sensitive detection of PUVA-induced DNA interstrand cross-links. Mutagenesis. 24(2). 173–181. 18 indexed citations

O’Brien, John, A.G. Renwick, Anne Constable, et al.. (2006). Approaches to the risk assessment of genotoxic carcinogens in food: A critical appraisal. Food and Chemical Toxicology. 44(10). 1613–1635. 90 indexed citations

Lea, Linda J., Paul Hepburn, Alison Wolfreys, & Paul Baldrick. (2004). Safety evaluation of phytosterol esters. Part 8. Lack of genotoxicity and subchronic toxicity with phytosterol oxides. Food and Chemical Toxicology. 42(5). 771–783. 50 indexed citations

10.

Wolfreys, Alison & David A. Basketter. (2004). Mutagens and Sensitizers—An Unequal Relationship?. Journal of Toxicology Cutaneous and Ocular Toxicology. 23(3). 197–205. 5 indexed citations

11.

Wolfreys, Alison, et al.. (2003). Safety evaluation of ice-structuring protein (ISP) type III HPLC 12 preparation. Lack of genotoxicity and subchronic toxicity. Food and Chemical Toxicology. 42(2). 321–333. 11 indexed citations

12.

Wolfreys, Alison & Paul Hepburn. (2002). Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phytosterol esters and the cholesterol derivative, 4-cholesten-3-one. Food and Chemical Toxicology. 40(4). 461–470. 40 indexed citations

13.

Bentham, Graham, Alison Wolfreys, Gino Cortopassi, et al.. (1999). Frequencies of hprt- mutations and bcl-2 translocations in circulating human lymphocytes are correlated with United Kingdom sunlight records. Mutagenesis. 14(6). 527–532. 24 indexed citations

14.

Henderson, L.M., et al.. (1998). The ability of the Comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis. 13(1). 89–94. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact